New Zealand markets closed

PODD Jun 2024 240.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.16000.0000 (0.00%)
At close: 03:20PM EDT
Full screen
Previous close0.1600
Open0.1600
Bid0.0000
Ask3.9000
Strike240.00
Expiry date2024-06-21
Day's range0.1600 - 0.1600
Contract rangeN/A
Volume2
Open interest48
  • Business Wire

    Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes

    ACTON, Mass., June 21, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today shared positive results from its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) type 2 diabetes pivotal trial at the American Diabetes Association (ADA) 84th Scientific Sessions in Orlando, Florida. This landmark study evaluated the impact of AID in a diverse group of people with type 2 diabetes who req

  • Insider Monkey

    Insulet (PODD) Faces Increasing Competition

    ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The positive momentum in 2023 continued in the first quarter of 2024, the stocks surged on the expectation of a soft landing of the economy and a slowdown in rate […]

  • Zacks

    Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System

    Insulet (PODD) debuts the Omnipod 5 AID system in France and announces new updates for the U.S. markets.